Chapstick Moisturizer Green Apple
NDC Package 0573-0728-40
Package Information
Chapstick Moisturizer Green Apple is useshelps prevent sunburnif used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sunhelps prevent and temporarily protects chafed, chapped or cracked lipshelps prevent and protect from the drying effects of wind and cold weather. Marketed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this product is identified by NDC 0573-0728 and is authorized under FDA application part347.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0573 - Glaxosmithkline Consumer Healthcare Holdings (us) Llc
- 0573-0728 - Chapstick Moisturizer Green Apple
- 0573-0728-40 - 3 CYLINDER in 1 BLISTER PACK / 4 g in 1 CYLINDER
- 0573-0728 - Chapstick Moisturizer Green Apple
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0573-0728). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0573-0728-40 identifies a specific commercial package of 3 cylinder in 1 blister pack / 4 g in 1 cylinder of Chapstick Moisturizer Green Apple, labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Consumer Healthcare Holdings (us) Llc on June 28, 2018. The current certification is valid through December 31, 2021.
How is this Glaxosmithkline Consumer Healthcare Holdings (us) Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00573072840. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.